Research and Markets (http://www.researchandmarkets.com/research/fc0207/strategic_analysis) has announced the addition of Frost & Sullivan's new report "Strategic Analysis of the Healthcare Industry in Zambia" to their offering.
The infectious disease diagnostics market in Zambia presents significant opportunities for manufacturers of low-cost diagnostic products. Infectious diseases, such as HIV/AIDS and Malaria, are receiving heightened attention from donors. However, under-developed laboratory infrastructure is hindering programmes such as anti-retroviral treatment (ART) rollout. Although rapid diagnostic testing (RDT) kits are still relatively new in Zambia, these low-cost products are expected to spur the market for diagnostics and ensure the continued expansion of mass rollout programmes.
"The increased uptake of low-cost RDT kits will drive the infectious disease diagnostics market," notes the analyst of this research. "This, in turn, will create a positive knock-on effect on ART roll-out." Growth in the diagnostics market is expected to be driven by the enhanced availability of low-cost diagnostic kits. Higher levels of donor funding will also promote market expansion.
Laboratory infrastructure in Zambia is under-developed and this, coupled with limited funding, means conventional laboratory tests are not accurate and feasible. Thus, for the market to grow to a significant extent, low-cost alternatives (in the form of RDT kits) would be the viable option. Uptake of these devices in Zambia, however, depends mostly on donor funding, which is expected to continue rising.